A pertinent point hottod and partially for these reasons I do not think we will 'accept' a takeover now.
I would not at all be surprised to discover the board has received lowball/opportunistic informal offers that have been dismissed out of hand.
I also expect the shareprice to rise over coming months on the back of new indications, confirmation of endpoints, and confirmation of Ph3 timeline and its approach. Finally I suspect that if we make it to Ph3 results, and they are as good as I expect, than we will see something similar to what happened last time with trofinetide/Retts, where we went up 700% or so post results and that any takeover premium will be on that figure and not on $14.39.
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
7.62%
!
$13.50

Neuren Media and Analyst Coverage, page-1505
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.50 |
Change
0.955(7.62%) |
Mkt cap ! $1.692B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $15.28M | 1.116M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 458 | $13.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.51 | 188 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 569 | 13.380 |
2 | 133 | 13.370 |
4 | 399 | 13.360 |
5 | 623 | 13.350 |
3 | 1094 | 13.340 |
Price($) | Vol. | No. |
---|---|---|
13.420 | 115 | 1 |
13.430 | 549 | 3 |
13.440 | 1454 | 4 |
13.450 | 349 | 2 |
13.460 | 1099 | 3 |
Last trade - 15.01pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online